成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. Apoptosis Anti-infection NF-κB MAPK/ERK Pathway
  2. Apoptosis Virus Protease NF-κB p38 MAPK JNK Caspase
  3. Angelicin

Angelicin  (Synonyms: 異補骨脂素; Isopsoralen)

目錄號: HY-N0763 純度: 99.98%
COA 產(chǎn)品使用指南 技術支持

Angelicin 是一種呋喃香豆素類 NF-κBMAPK 信號抑制劑,具有抗炎、抗病毒和抗腫瘤活性。Angelicin 能夠抑制 γ-皰疹病毒 (如 MHV-68) 裂解復制,作用于病毒感染早期,并可能抑制 RTA 基因表達 (IC50=28.95 μM)。Angelicin 還通過抑制 NF-κB 磷酸化和核轉位,以及抑制 p38JNK 磷酸化來減輕炎癥反應。Angelicin 下調(diào)抗凋亡蛋白 (如 Bcl-2Bcl-xLMcl-1) 并激活 caspase-9caspase-3 來誘導神經(jīng)母細胞瘤細胞的凋亡 (apoptosis)。

MCE 的所有產(chǎn)品僅用作科學研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務

Angelicin Chemical Structure

Angelicin Chemical Structure

CAS No. : 523-50-2

1.  客戶無需承擔相應的運輸費用。

2.  同一機構(單位)同一產(chǎn)品試用裝僅限申領一次,同一機構(單位)一年內(nèi)

     可免費申領三個不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶。

規(guī)格 價格 是否有貨 數(shù)量
10 mM * 1 mL in DMSO ¥550
In-stock
25 mg ¥500
In-stock
50 mg ¥800
In-stock
100 mg ¥1200
In-stock
200 mg   詢價  
500 mg   詢價  

* Please select Quantity before adding items.

Customer Review

Other Forms of Angelicin:

  • 生物活性

  • 純度 & 產(chǎn)品資料

  • 參考文獻

生物活性

Angelicin is a furanocoumarin compound that functions as an inhibitor of NF-κB and MAPK signaling pathways, exhibiting anti-inflammatory, antiviral, and antitumor activities. It suppresses the lytic replication of γ-herpesviruses, such as MHV-68, early during viral infection, potentially inhibiting RTA gene expression (IC50=28.95 μM). Angelicin also mitigates inflammation by inhibiting the phosphorylation and nuclear translocation of NF-κB, and the phosphorylation of p38 and JNK. Furthermore, it induces apoptosis in neuroblastoma cells by downregulating anti-apoptotic proteins like Bcl-2, Bcl-xL, and Mcl-1, while activating caspase-9 and caspase-3.

IC50 & Target

Caspase-9

 

Caspase-3

 

細胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
> 10 μM
Compound: 21
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
[PMID: 25710081]
HL-60 IC50
0.9 μM
Compound: Ang
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
[PMID: 21397509]
HL-60 IC50
0.9 μM
Compound: 2, ANG
Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human HL-60 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
HL-60 IC50
1.2 μM
Compound: Ang
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human HL60 cells after 72 hrs by MTT assay
[PMID: 21397509]
HL-60 IC50
1.2 μM
Compound: 2, ANG
Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human HL-60 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
HL-60 GI50
1.2 μM
Compound: Ang
Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human HL60 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
HT-1080 IC50
15.7 μM
Compound: 2, ANG
Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human HT1080 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
HT-1080 IC50
15.7 μM
Compound: Angelicin
Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
Inhibition of cell growth after irradiation at UVA dose of 2.6 J/cmE-2 in HT1080 human fibrosarcoma cell line
[PMID: 12873520]
HT-1080 IC50
2.5 μM
Compound: Angelicin
Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
Inhibition of cell growth after irradiation at UVA dose of 6.5 J/cmE-2 in HT1080 human fibrosarcoma cell line
[PMID: 12873520]
HT-1080 IC50
2.6 μM
Compound: 2, ANG
Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human HT1080 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
HT-1080 IC50
2.6 μM
Compound: Angelicin
Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
Inhibition of cell growth after irradiation at UVA dose of 3.2 J/cmE-2 in HT1080 human fibrosarcoma cell line
[PMID: 12873520]
Jurkat IC50
> 20 μM
Compound: 2, Ang
Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
Cytotoxicity against human Jurkat cells after 72 hrs by MTT assay
[PMID: 19230658]
Jurkat IC50
0.9 μM
Compound: Ang
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
[PMID: 21397509]
Jurkat IC50
0.9 μM
Compound: Ang
Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human Jurkat cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
Jurkat IC50
0.9 μM
Compound: 2, ANG
Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human JURKAT cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
Jurkat IC50
0.9 μM
Compound: 2, Ang
Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
Phototoxicity against human Jurkat cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
[PMID: 19230658]
Jurkat IC50
1 μM
Compound: Ang
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human Jurkat cells after 72 hrs by MTT assay
[PMID: 21397509]
Jurkat IC50
1 μM
Compound: Ang
Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human Jurkat cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
Jurkat GI50
1 μM
Compound: Ang
Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human Jurkat cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
K562 IC50
> 10 μM
Compound: 21
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
[PMID: 25710081]
K562 IC50
> 20 μM
Compound: 2, Ang
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
Cytotoxicity against human K562 cells after 72 hrs by MTT assay
[PMID: 19230658]
K562 IC50
1 μM
Compound: Ang
Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human K562 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
K562 IC50
1.2 μM
Compound: Ang
Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human K562 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
LoVo IC50
> 20 μM
Compound: 2, Ang
Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
Cytotoxicity against human LoVo cells after 72 hrs by MTT assay
[PMID: 19230658]
LoVo IC50
0.9 μM
Compound: 2, ANG
Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human LoVo cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
LoVo IC50
0.9 μM
Compound: 2, Ang
Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
Phototoxicity against human LoVo cells exposed to irradiation with 3.75 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
[PMID: 19230658]
LoVo IC50
1.1 μM
Compound: Ang
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
[PMID: 21397509]
LoVo GI50
1.11 μM
Compound: Ang
Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human LoVo cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
LoVo IC50
1.5 μM
Compound: Ang
Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human LoVo cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
LoVo IC50
1.6 μM
Compound: 2, ANG
Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human LoVo cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
LoVo IC50
1.6 μM
Compound: 2, Ang
Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
Phototoxicity against human LoVo cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
[PMID: 19230658]
LoVo IC50
3.6 μM
Compound: Ang
Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human LoVo cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
LoVo IC50
4 μM
Compound: Ang
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human LoVo cells after 72 hrs by MTT assay
[PMID: 21397509]
LoVo GI50
4 μM
Compound: Ang
Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human LoVo cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
MCF7 IC50
1.5 μM
Compound: Ang
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
[PMID: 21397509]
MCF7 IC50
1.5 μM
Compound: Ang
Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human MCF7 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
MCF7 GI50
1.5 μM
Compound: Ang
Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 3.75 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
MCF7 IC50
4.4 μM
Compound: Ang
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human MCF7 cells after 72 hrs by MTT assay
[PMID: 21397509]
MCF7 IC50
4.4 μM
Compound: Ang
Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human MCF7 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
MCF7 GI50
4.42 μM
Compound: Ang
Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
Photocytotoxicity against human MCF7 cells assessed as growth inhibition at 2.5 J/cm'2 irradiation for 30 mins followed by drug treated for 72 hrs by MTT assay
[PMID: 26295175]
NCTC-2544 IC50
> 20 μM
Compound: 2, Ang
Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
Cytotoxicity against human NCTC-2544 cells after 72 hrs by MTT assay
[PMID: 19230658]
NCTC-2544 IC50
0.9 μM
Compound: Ang
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
Phototoxicity in 3.75 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
[PMID: 21397509]
NCTC-2544 IC50
0.9 μM
Compound: Ang
Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human sNCTC-2544 cells irradiated with 3.75 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
NCTC-2544 IC50
1.5 μM
Compound: 2, ANG
Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 3.75 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
NCTC-2544 IC50
4.2 μM
Compound: Ang
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
Phototoxicity in 2.5 J/cm'2 UV-A irradiated human NCTC-2544 cells after 72 hrs by MTT assay
[PMID: 21397509]
NCTC-2544 IC50
4.2 μM
Compound: Ang
Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
Phototoxicity against human sNCTC-2544 cells irradiated with 2.5 J/cm'2 after 72 hrs by MTT assay
[PMID: 20627596]
NCTC-2544 IC50
4.2 μM
Compound: 2, ANG
Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
Photocytotoxicity against human NCTC 2544 cells treated 30 mins before 2.5 J/cm'2 UVA irradiation measured after 72 hrs by MTT assay
[PMID: 18951030]
NCTC-2544 IC50
4.2 μM
Compound: 2, Ang
Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
Phototoxicity against human NCTC-2544 cells exposed to irradiation with 2.5 J/cm'2 UVA light prior to 72 hrs drug exposure by MTT assay
[PMID: 19230658]
體外研究
(In Vitro)

Angelicin (30-50 μM; 48 h) 在 SH-SY5Y 細胞中誘導細胞凋亡,引起 Bcl-2、Bcl-xL 和 Mcl-1 蛋白表達的下調(diào),并激活 caspase-9 和 caspase-3 的裂解,導致細胞凋亡[1]。
Angelicin (28.95 μM; 48 h) 在 MHV-68 感染的 BHK21 細胞中抑制病毒復制,引起病毒蛋白 ORF45 和 ORF65 的表達下降,并減少病毒基因組復制和 RTA mRNA 的表達[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

體內(nèi)研究
(In Vivo)

Angelicin (1、5、10 mg/kg;腹腔注射;給藥1次,于 LPS 誘導前 1 小時給藥) 在 LPS 誘導的小鼠急性肺損傷模型中具有抗炎作用,通過抑制 MAPK 和 NF-κB 通路減少炎癥細胞浸潤和細胞因子產(chǎn)生[3]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: LPS-induced acute lung injury BALB/c mouse model[3]
Dosage: 1, 5, 10 mg/kg
Administration: ip
Result: Reduced the number of inflammatory cells, lung wet-to-dry weight ratio, MPO activity, reduced TNF-α and IL-6 levels, and improved lung tissue pathological changes.
分子量

186.16

Formula

C11H6O3

CAS 號
性狀

固體

顏色

White to off-white

中文名稱

異補骨脂素;異香檸檬烯;異佛手柑內(nèi)酯;異補骨酯素;當歸素

結構分類
初始來源
運輸條件

Room temperature in continental US; may vary elsewhere.

儲存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 2 years
-20°C 1 year
溶解性數(shù)據(jù)
細胞實驗: 

DMSO 中的溶解度 : 33.33 mg/mL (179.04 mM; 超聲助溶; 吸濕的 DMSO 對產(chǎn)品的溶解度有顯著影響,請使用新開封的 DMSO)

配制儲備液
濃度 溶劑體積 質量 1 mg 5 mg 10 mg
1 mM 5.3717 mL 26.8586 mL 53.7172 mL
5 mM 1.0743 mL 5.3717 mL 10.7434 mL
查看完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C儲存時,請在2年內(nèi)使用, -20°C儲存時,請在1年內(nèi)使用。

  • 摩爾計算器

  • 稀釋計算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

動物實驗:

請根據(jù)您的 實驗動物和給藥方式 選擇適當?shù)娜芙夥桨浮?

以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:
——為保證實驗結果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當保存;體內(nèi)實驗的工作液,建議您現(xiàn)用現(xiàn)配,當天使用;
以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

  • 方案 一

    請依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (13.43 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 DMSO 儲備液加到 400 μL PEG300 中,混合均勻;再向上述體系中加入 50 μL Tween-80,混合均勻;然后再繼續(xù)加入 450 μL 生理鹽水 定容至 1 mL

    生理鹽水的配制:將 0.9 g 氯化鈉,溶解于 ddH?O 并定容至 100 mL,可以得到澄清透明的生理鹽水溶液。
  • 方案 二

    請依序添加每種溶劑: 10% DMSO    90% Corn Oil

    Solubility: ≥ 2.5 mg/mL (13.43 mM); 澄清溶液

    此方案可獲得 ≥ 2.5 mg/mL(飽和度未知)的澄清溶液,此方案實驗周期在半個月以上的動物實驗酌情使用。

    1 mL 工作液為例,取 100 μL 25.0 mg/mL 的澄清 DMSO 儲備液加到 900 μL玉米油中,混合均勻。

動物溶解方案計算器
請輸入動物實驗的基本信息:

給藥劑量

mg/kg

動物的平均體重

g

每只動物的給藥體積

μL

動物數(shù)量

由于實驗過程有損耗,建議您多配一只動物的量
請輸入您的動物體內(nèi)配方組成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的動物是免疫缺陷鼠或者體弱鼠,建議 DMSO 中的在最后工作液體系中的占比盡量不超過 2%。
方案所需 助溶劑 包括:DMSO, ,均可在 MCE 網(wǎng)站選購。 Tween 80,均可在 MCE 網(wǎng)站選購。
計算結果
工作液所需濃度 : mg/mL
儲備液配制方法 : mg 藥物溶于 μL  DMSO(母液濃度為 mg/mL)。
您所需的儲備液濃度超過該產(chǎn)品的實測溶解度,以下方案僅供參考,如有需要,請與 MCE 中國技術支持聯(lián)系。
動物實驗體內(nèi)工作液的配制方法 : 取 μL DMSO 儲備液,加入 μL  μL ,混合均勻至澄清,再加 μL Tween 80,混合均勻至澄清,再加 μL 生理鹽水。
連續(xù)給藥周期超過半月以上,請謹慎選擇該方案。
請確保第一步儲備液溶解至澄清狀態(tài),從左到右依次添加助溶劑。您可采用超聲加熱 (超聲清洗儀,建議頻次 20-40 kHz),渦旋吹打等方式輔助溶解。
純度 & 產(chǎn)品資料

純度: 99.98%

參考文獻

完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限:-80°C, 2 years; -20°C, 1 year。-80°C儲存時,請在2年內(nèi)使用, -20°C儲存時,請在1年內(nèi)使用。

可選溶劑 濃度 溶劑體積 質量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 5.3717 mL 26.8586 mL 53.7172 mL 134.2931 mL
5 mM 1.0743 mL 5.3717 mL 10.7434 mL 26.8586 mL
10 mM 0.5372 mL 2.6859 mL 5.3717 mL 13.4293 mL
15 mM 0.3581 mL 1.7906 mL 3.5811 mL 8.9529 mL
20 mM 0.2686 mL 1.3429 mL 2.6859 mL 6.7147 mL
25 mM 0.2149 mL 1.0743 mL 2.1487 mL 5.3717 mL
30 mM 0.1791 mL 0.8953 mL 1.7906 mL 4.4764 mL
40 mM 0.1343 mL 0.6715 mL 1.3429 mL 3.3573 mL
50 mM 0.1074 mL 0.5372 mL 1.0743 mL 2.6859 mL
60 mM 0.0895 mL 0.4476 mL 0.8953 mL 2.2382 mL
80 mM 0.0671 mL 0.3357 mL 0.6715 mL 1.6787 mL
100 mM 0.0537 mL 0.2686 mL 0.5372 mL 1.3429 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱:

 

* 需求量:

* 客戶姓名:

 

* Email:

* 電話:

 

* 公司或機構名稱:

   留言給我們:

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱:
Angelicin
目錄號:
HY-N0763
需求量: